Paid Clinical Trials Plainfield
Discover 2,260 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young AdultsNivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
Sponsor:
Sabine Mueller, MD, PhD
Location:
Code:
NCT05465174
Conditions
Craniopharyngioma, Child
Craniopharyngioma
Recurrent Craniopharyngioma
Eligibility Criteria
Sex: All
Age: 1 - 39
Healthy Volunteers: Not accepted
Interventions
Nivolumab
Tovorafenib
Study of Olutasidenib and Temozolomide in HGGStudy of Olutasidenib and Temozolomide in HGG
Sponsor:
Rigel Pharmaceuticals
Location:
Code:
NCT06161974
Conditions
High Grade Glioma
Astrocytoma
Astrocytoma, Grade III
Astrocytoma, Grade IV
Diffuse Intrinsic Pontine Glioma
Eligibility Criteria
Sex: All
Age: 12 - 39
Healthy Volunteers: Not accepted
Interventions
Olutasidenib + TMZ
Safety and Effectiveness of the PXL-Platinum 330 SystemSafety and Effectiveness of the PXL-Platinum 330 System
Sponsor:
Colorado Eye Consultants/Cornea Consultants of Colorado
Location:
Code:
NCT04401865
Conditions
Corneal Ectasia
Keratoconus
Pellucid Marginal Corneal Degeneration
Eligibility Criteria
Sex: All
Age: 8+
Healthy Volunteers: Not accepted
Interventions
PXL-330 Platinum device for crosslinking with Peschke riboflavin solution
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder CancerA Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Sponsor:
Janssen Research & Development, LLC
Location:
Code:
NCT06319820
Conditions
Non-Muscle Invasive Bladder Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TAR-210
Gemcitabine
MMC
Study of LP-184 in Patients with Advanced Solid TumorsStudy of LP-184 in Patients with Advanced Solid Tumors
Sponsor:
Lantern Pharma Inc.
Location:
Code:
NCT05933265
Conditions
Advanced Solid Tumor
Metastatic Solid Tumor
GBM
TNBC - Triple-Negative Breast Cancer
NSCLC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LP-184
Spironolactone
Olaparib
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
Sponsor:
Incyte Corporation
Location:
Code:
NCT06516965
Conditions
Prurigo Nodularis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Povorcitinib
Placebo
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate CancerA Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Sponsor:
Genentech, Inc.
Location:
Code:
NCT05800665
Conditions
Advanced Prostate Cancer
Metastatic Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
RO7656594
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)
Sponsor:
Biogen
Location:
Code:
NCT05531565
Conditions
Subacute Cutaneous Lupus Erythematosus
Chronic Cutaneous Lupus Erythematosus
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Litifilimab
Placebo
Facilitating Advance Care Planning Discussions for People With Advance CancerFacilitating Advance Care Planning Discussions for People With Advance Cancer
Sponsor:
University of Illinois at Chicago
Location:
Code:
NCT06061965
Conditions
Resilience, Psychological
Advance Care Planning
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Web-based resilience-building intervention
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Sponsor:
Children's Oncology Group
Location:
Code:
NCT05235165
Conditions
Metastatic Malignant Neoplasm in the Lung
Metastatic Osteosarcoma
Osteosarcoma
Eligibility Criteria
Sex: All
Age: 0 - 50
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Questionnaire Administration
Thoracoscopy
Thoracotomy